Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > Level II end of day

<< Previous

Bullboard Posts

Next >>

Post by Dandy07on Apr 29, 2020 7:52pm

184 Views

Post# 30969127

Level II end of day

Here's your Level II Quotes. 15:59 EST (3:59pm) was the last trade.

Last:

0.045

Change:

-0.005

Volume:

512,790

Last Trade:

15:59

Level ll Quote
Bid			Ask
Price	Total Size	# of Orders	Price	Total Size	# of Orders

$0.04	1791000	19	$0.045	2000	1
$0.035	763000	12	$0.05	198000	7
$0.03	870000	20	$0.055	410000	11
$0.025	771000	14	$0.06	731000	11
$0.02	453000	11	$0.065	915000	8
$0.015	600000	4	$0.07	575000	9
			$0.075	399000	6
			$0.08	374000	7
			$0.085	330000	4
			$0.09	232000	5